{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:15:51Z","timestamp":1776215751668,"version":"3.50.1"},"reference-count":19,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mycobacteriol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijmy.ijmy_159_18","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T08:34:25Z","timestamp":1552898065000},"page":"89","source":"Crossref","is-referenced-by-count":23,"title":["Ursodeoxycholic acid attenuates hepatotoxicity of multidrug treatment of mycobacterial infections: A prospective pilot study"],"prefix":"10.4103","volume":"8","author":[{"given":"SusanneM","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Rostig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Schiffl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2212-5531.253952-1","first-page":"325","volume-title":"Tuberculosis guideline for adults \u2013 Guideline for diagnosis and treatment of tuberculosis including LTBI testing and treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)","author":"Schaberg","year":"2017","journal-title":"Pneumologie"},{"key":"key-10.4103\/2212-5531.253952-2","first-page":"231","volume-title":"Drug-induced liver injury from antituberculous treatment: A retrospective study from a large TB centre in the UK","author":"Abbara","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/2212-5531.253952-3","first-page":"883","volume-title":"Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity","author":"Chen","year":"2015","journal-title":"Arch Toxicol"},{"key":"key-10.4103\/2212-5531.253952-4","doi-asserted-by":"crossref","unstructured":"Yew WW, Chang KC, Chan DP. Oxidative stress and first-line antituberculosis drug-induced hepatotoxicity. Antimicrob Agents Chemother 2018;62. pii: e02637-17.","DOI":"10.1128\/AAC.02637-17"},{"key":"key-10.4103\/2212-5531.253952-5","first-page":"37","volume-title":"Hepatotoxicity related to anti-tuberculosis drugs: Mechanisms and management","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"key-10.4103\/2212-5531.253952-6","first-page":"935","volume-title":"An official ATS statement: Hepatotoxicity of antituberculosis therapy","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2212-5531.253952-7","first-page":"256","volume-title":"Drug induced hepatitis with anti-tubercular chemotherapy: Challenges and difficulties in treatment","author":"Kishore","year":"2007","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"key-10.4103\/2212-5531.253952-8","first-page":"351","volume-title":"Ursodeoxycholic acid can improve liver transaminase quantities in children with anticonvulsant drugs hepatotoxicity: A pilot study","author":"Asgarshirazi","year":"2015","journal-title":"Acta Med Iran"},{"key":"key-10.4103\/2212-5531.253952-9","first-page":"CD000222","volume-title":"Ursodeoxycholic acid for cystic fibrosis-related liver disease","author":"Cheng","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2212-5531.253952-10","first-page":"632","volume-title":"The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: A meta-analysis including non-randomized studies","author":"Grand'Maison","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.4103\/2212-5531.253952-11","first-page":"192","volume-title":"Ursodeoxycholic acid in treatment of non-cholestatic liver diseases: A systematic review","author":"Reardon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"key-10.4103\/2212-5531.253952-12","first-page":"75","volume-title":"Ursodeoxycholic acid in the treatment of liver diseases","author":"Saksena","year":"1997","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/2212-5531.253952-13","first-page":"54","volume-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","author":"Wree","year":"2011","journal-title":"Digestion"},{"key":"key-10.4103\/2212-5531.253952-14","first-page":"53","volume-title":"The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice","author":"Chen","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/2212-5531.253952-15","doi-asserted-by":"crossref","unstructured":"Alpana M, Daga MK, Aggarwal S, Nidhi A. Treatment for tuberculosis in a patient with Dubin-Johnson syndrome. BMJ Case Rep 2015;2015. pii: bcr2015211123.","DOI":"10.1136\/bcr-2015-211123"},{"key":"key-10.4103\/2212-5531.253952-16","first-page":"668","volume-title":"Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: A retrospective analysis","author":"Saito","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/2212-5531.253952-17","first-page":"91","volume-title":"Principles of diagnosis and therapy of drug-induced liver injury in children with tuberculosis","author":"Borzakova","year":"2018","journal-title":"Ross Vestn Perinatol Pediatr"},{"key":"key-10.4103\/2212-5531.253952-18","first-page":"591","volume-title":"Isoniazid-induced acute liver failure during preventive therapy for latent tuberculosis infection","author":"Miyazawa","year":"2015","journal-title":"Intern Med"},{"key":"key-10.4103\/2212-5531.253952-19","first-page":"244","volume-title":"Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans","author":"Marschall","year":"2012","journal-title":"Digestion"}],"container-title":["International Journal of Mycobacteriology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:56:19Z","timestamp":1682081779000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijmyco.org\/text.asp?2019\/8\/1\/89\/253952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["253952"],"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_159_18","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}